Back to Library

The Freemasons Fund For Surgical Research

scraped content
Universal
Priority: 4
AI-Generated Summary
Generated January 25th, 2026 • gpt-4o-mini

The Freemasons Fund For Surgical Research (FFSR) supports innovative medical research, focusing on various critical areas such as deep infections post-knee surgery, prostate cancer biopsy testing, and advanced bowel cancer treatment. Established in 1967, the fund has received over £5.9 million in donations, primarily from Freemasons, with a current value of £7 million. The fund operates independently, managed by Trustees appointed by the Grand Master, including Chairman Justin Ash. Recent research initiatives include investigating pancreatic cancer biomarkers and the implications of frailty in emergency surgery. The FFSR aims to enhance medical outcomes through rigorous research and development, contributing significantly to advancements in surgical practices and cancer treatment. For more details, visit the Freemasons’ Fund for Surgical Research website.

Created:

December 9th, 2025

Last Updated:

February 10th, 2026

Document Type:

scraped content

Category:

uncategorized

Ask AI About This DocumentView Source
Original Document
View Source

External source: www.ugle.org.uk

The Freemasons Fund For Surgical Research (FFSR)

Recent Research Fellows' Work:

  • Tackling deep infection following knee joint replacement surgery
  • Improving testing of prostate cancer biopsies
  • Stem cell construction of cartilage for ear reconstruction
  • Enhancing outcomes for advanced bowel cancer patients
  • Addressing bowel disease in premature babies
  • Identifying women at higher risk of breast cancer

Current Research Focus:

  • Investigating biomarkers in pancreatic cancers
  • Understanding frailty implications in emergency surgery
  • Examining liquid biopsies for thyroid cancer treatment
  • Studying gastric cancer development

Funding Overview:

  • 100% of the fund is donated by Freemasons
  • £1M+ donated in 1967 at the fund's launch
  • £2.4M donated in 2014 by Royal Arch Companions for their bicentenary
  • £5.9M total donations since 1967
  • Current fund value: £7M
  • Average annual donation to RCS: £220,000

History:

  • Established in 1967 following an appeal by the Earl of Scarborough for a new Masonic charity.
  • Initial donations were invested to sustain annual grants while maintaining capital value.
  • The fund operates independently of the festival system, relying on careful investments and occasional gifts.

Trustees:

  • The fund is managed by Trustees appointed by the Grand Master, with no employed staff.
  • Current Trustees include Justin Ash (Chairman), Jolyon Berry, Paul Copsey, and others.

Research Impact:

  • Supports innovative treatments for medical conditions.
  • Recent projects include investigating biomarkers for cancer diagnosis and understanding gastric cancer development.

For further information, visit the Freemasons’ Fund for Surgical Research website.